P01019 (ANGT_HUMAN) Homo sapiens (Human)
Angiotensinogen UniProtKBInterProSTRINGInteractive Modelling
476 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: A0A7P0T8D1
It is possible new templates exist for this target since these models were created.
Available Structures
22 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom |
Heteromer P00797; | 1×NAG; 1×NAG; 10×SO4; 1×GOL; | ||||
Assess | ||||||
Crystal structure of human angiotensinogen complexed with renin |
Heteromer P00797; | |||||
Assess | ||||||
Human angiotensin-converting enzyme in complex with angiotensin-II |
Heteromer P12821; | 1×NAG; 2×CL; 1×ZN; 1×PE4; 1×NAG; 5×ACT; | ||||
Assess | ||||||
Structure of human DPP3 in complex with angiotensin-II |
Heteromer Q9NY33; | 1×MG; 1×K; | ||||
Assess | ||||||
Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II |
Heteromer P0ABE7; P30556; | 1×NAG; 2×CL; | ||||
Assess | ||||||
ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH HUMAN ANGIOTENSIN II |
Heteromer P01837; | |||||
Assess | ||||||
Angiotensin II type 2 receptor with ligand |
Heteromer P0ABE7; P50052; | |||||
Assess | ||||||
Human aminopeptidase N (CD13) in complex with angiotensin IV |
Heteromer P15144; | 1×NAG; 1×NAG; 5×NAG; 11×SO4; | ||||
Assess | ||||||
Crystal structure of the DAP BII octapeptide complex |
Heteromer V5YM14; | 9×GOL; 4×ZN; | ||||
Assess | ||||||
Complex structure of angiotensin II type 2 receptor with Fab |
Heteromer P0ABE7; P50052; | |||||
Assess | ||||||
Crystal structure of AT2R-BRIL and SRP2070_Fab complex |
Heteromer P0ABE7; P50052; | |||||
Assess | ||||||
Crystal structure of the DAP BII hexapeptide complex I |
Heteromer V5YM14; | 12×GOL; 4×ZN; | ||||
Assess | ||||||
Crystal structure of ANCE in complex with Angiotensin-II |
Heteromer Q10714; | 1×NAG; 1×ZN; 2×NAG; | ||||
Assess | ||||||
E. coli Microcin-processing metalloprotease TldD/E with DRVY angiotensin fragment bound |
Heteromer P0AFK0; P0AGG8; | 1×ZN; 2×MES; 5×EDO; 2×NA; | ||||
Assess | ||||||
E. coli Microcin-processing metalloprotease TldD/E with angiotensin analogue bound |
Heteromer P0AFK0; P0AGG8; | 1×ZN; 2×MES; 5×EDO; 2×NA; | ||||
Assess | ||||||
Crystal structure of human glycosylated angiotensinogen | monomer | 1×NAG; | ||||
Assess | ||||||
Crystal structure of reactive center loop (RCL) cleaved angiotensinogen | monomer | 1×NAG; | ||||
Assess | ||||||
Crystal structure of human angiotensinogen | monomer | |||||
Assess | ||||||
Crystal structure of human angiotensin I-deleted angiotensinogen | monomer | |||||
Assess | ||||||
Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structur… | monomer | |||||
Assess | ||||||
Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structur… | monomer | |||||
Assess | ||||||
Angiotensin 1-7 | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
2wxw.1.A | monomer | 0.80 | 100.00 | |||
Assess |